Research Article
Dynamics of SOX2 and CDX2 Expression in Barrett’s Mucosa
Table 1
Primary antibodies and immunohistochemistry conditions used in this study.
| Antibody | Clone | Antigen retrieval buffer | Antigen retrieval conditions | Dilution | Incubation time (min) | Localization | Source |
| CDX2 | CDX2-88 | Citrate buffer 10 mM pH 6.0 | 40 minutes at 98°C | 1 : 50 | Overnight (4°C) | Nuclear | Biogenex, San Ramon, CA | MUC2 | PMH1 | 0.1 U/mL neuraminidase | 2 h at 37°C | Undiluted | Overnight (4°C) | Cytoplasmatic | Supernatant [28] | MUC5AC | CLH2 | None | None | 1 : 10 | Overnight (4°C) | Cytoplasmatic | Supernatant [28] | MUC6 | CLH5 | None | None | 1 : 10 | Overnight (4°C) | Cytoplasmatic | Supernatant [28] | SOX2 | SP-76 | EDTA 10 mM pH 8.0 | 40 minutes at 98°C | 1 : 50 | 1 h (room temperature) | Nuclear | Cell Marque, Rockling, CA |
|
|
Neuraminidase from Clostridium perfringens type VI (Sigma) was diluted in sodium acetate buffer (pH 5.5).
|